Click for best price
Preclinical Drug Development Services Market Size, Share 2022
This report contains market size and forecasts of Preclinical Drug Development Services in Global, including the following market information:
Global Preclinical Drug Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Preclinical Drug Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
API Preparation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Preclinical Drug Development Services include Wuxi AppTec, Labcorp, Charles River, Eurofins Scientific, PPD, Inc., ICON Plc., Pharmaron, Inotiv and ChemPartner, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Preclinical Drug Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Preclinical Drug Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Preclinical Drug Development Services Market Segment Percentages, by Type, 2021 (%)
API Preparation
Formulation Studies
Safety Studies
ADME Stuies
Global Preclinical Drug Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Preclinical Drug Development Services Market Segment Percentages, by Application, 2021 (%)
Pharmaceutical
Bio-pharmaceutical
Global Preclinical Drug Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Preclinical Drug Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Preclinical Drug Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Preclinical Drug Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Wuxi AppTec
Labcorp
Charles River
Eurofins Scientific
PPD, Inc.
ICON Plc.
Pharmaron
Inotiv
ChemPartner
JOINN Lab
EVOTEC
Medicilon
Noble Life Sciences
| Report Attributes |
Report Details |
| Report Title |
Preclinical Drug Development Services Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
64 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Preclinical Drug Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Preclinical Drug Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Preclinical Drug Development Services Overall Market Size
2.1 Global Preclinical Drug Development Services Market Size: 2021 VS 2028
2.2 Global Preclinical Drug Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Preclinical Drug Development Services Players in Global Market
3.2 Top Global Preclinical Drug Development Services Companies Ranked by Revenue
3.3 Global Preclinical Drug Development Services Revenue by Companies
3.4 Top 3 and Top 5 Preclinical Drug Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Preclinical Drug Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Preclinical Drug Development Services Players in Global Market
3.6.1 List of Global Tier 1 Preclinical Drug Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Preclinical Drug Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Preclinical Drug Development Services Market Size Markets, 2021 & 2028
4.1.2 API Preparation
4.1.3 Formulation Studies
4.1.4 Safety Studies
4.1.5 ADME Stuies
4.2 By Type - Global Preclinical Drug Development Services Revenue & Forecasts
4.2.1 By Type - Global Preclinical Drug Development Services Revenue, 2017-2022
4.2.2 By Type - Global Preclinical Drug Development Services Revenue, 2023-2028
4.2.3 By Type - Global Preclinical Drug Development Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Preclinical Drug Development Services Market Size, 2021 & 2028
5.1.2 Pharmaceutical
5.1.3 Bio-pharmaceutical
5.2 By Application - Global Preclinical Drug Development Services Revenue & Forecasts
5.2.1 By Application - Global Preclinical Drug Development Services Revenue, 2017-2022
5.2.2 By Application - Global Preclinical Drug Development Services Revenue, 2023-2028
5.2.3 By Application - Global Preclinical Drug Development Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Preclinical Drug Development Services Market Size, 2021 & 2028
6.2 By Region - Global Preclinical Drug Development Services Revenue & Forecasts
6.2.1 By Region - Global Preclinical Drug Development Services Revenue, 2017-2022
6.2.2 By Region - Global Preclinical Drug Development Services Revenue, 2023-2028
6.2.3 By Region - Global Preclinical Drug Development Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Preclinical Drug Development Services Revenue, 2017-2028
6.3.2 US Preclinical Drug Development Services Market Size, 2017-2028
6.3.3 Canada Preclinical Drug Development Services Market Size, 2017-2028
6.3.4 Mexico Preclinical Drug Development Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Preclinical Drug Development Services Revenue, 2017-2028
6.4.2 Germany Preclinical Drug Development Services Market Size, 2017-2028
6.4.3 France Preclinical Drug Development Services Market Size, 2017-2028
6.4.4 U.K. Preclinical Drug Development Services Market Size, 2017-2028
6.4.5 Italy Preclinical Drug Development Services Market Size, 2017-2028
6.4.6 Russia Preclinical Drug Development Services Market Size, 2017-2028
6.4.7 Nordic Countries Preclinical Drug Development Services Market Size, 2017-2028
6.4.8 Benelux Preclinical Drug Development Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Preclinical Drug Development Services Revenue, 2017-2028
6.5.2 China Preclinical Drug Development Services Market Size, 2017-2028
6.5.3 Japan Preclinical Drug Development Services Market Size, 2017-2028
6.5.4 South Korea Preclinical Drug Development Services Market Size, 2017-2028
6.5.5 Southeast Asia Preclinical Drug Development Services Market Size, 2017-2028
6.5.6 India Preclinical Drug Development Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Preclinical Drug Development Services Revenue, 2017-2028
6.6.2 Brazil Preclinical Drug Development Services Market Size, 2017-2028
6.6.3 Argentina Preclinical Drug Development Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Preclinical Drug Development Services Revenue, 2017-2028
6.7.2 Turkey Preclinical Drug Development Services Market Size, 2017-2028
6.7.3 Israel Preclinical Drug Development Services Market Size, 2017-2028
6.7.4 Saudi Arabia Preclinical Drug Development Services Market Size, 2017-2028
6.7.5 UAE Preclinical Drug Development Services Market Size, 2017-2028
7 Players Profiles
7.1 Wuxi AppTec
7.1.1 Wuxi AppTec Corporate Summary
7.1.2 Wuxi AppTec Business Overview
7.1.3 Wuxi AppTec Preclinical Drug Development Services Major Product Offerings
7.1.4 Wuxi AppTec Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.1.5 Wuxi AppTec Key News
7.2 Labcorp
7.2.1 Labcorp Corporate Summary
7.2.2 Labcorp Business Overview
7.2.3 Labcorp Preclinical Drug Development Services Major Product Offerings
7.2.4 Labcorp Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.2.5 Labcorp Key News
7.3 Charles River
7.3.1 Charles River Corporate Summary
7.3.2 Charles River Business Overview
7.3.3 Charles River Preclinical Drug Development Services Major Product Offerings
7.3.4 Charles River Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.3.5 Charles River Key News
7.4 Eurofins Scientific
7.4.1 Eurofins Scientific Corporate Summary
7.4.2 Eurofins Scientific Business Overview
7.4.3 Eurofins Scientific Preclinical Drug Development Services Major Product Offerings
7.4.4 Eurofins Scientific Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.4.5 Eurofins Scientific Key News
7.5 PPD, Inc.
7.5.1 PPD, Inc. Corporate Summary
7.5.2 PPD, Inc. Business Overview
7.5.3 PPD, Inc. Preclinical Drug Development Services Major Product Offerings
7.5.4 PPD, Inc. Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.5.5 PPD, Inc. Key News
7.6 ICON Plc.
7.6.1 ICON Plc. Corporate Summary
7.6.2 ICON Plc. Business Overview
7.6.3 ICON Plc. Preclinical Drug Development Services Major Product Offerings
7.6.4 ICON Plc. Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.6.5 ICON Plc. Key News
7.7 Pharmaron
7.7.1 Pharmaron Corporate Summary
7.7.2 Pharmaron Business Overview
7.7.3 Pharmaron Preclinical Drug Development Services Major Product Offerings
7.7.4 Pharmaron Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.7.5 Pharmaron Key News
7.8 Inotiv
7.8.1 Inotiv Corporate Summary
7.8.2 Inotiv Business Overview
7.8.3 Inotiv Preclinical Drug Development Services Major Product Offerings
7.8.4 Inotiv Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.8.5 Inotiv Key News
7.9 ChemPartner
7.9.1 ChemPartner Corporate Summary
7.9.2 ChemPartner Business Overview
7.9.3 ChemPartner Preclinical Drug Development Services Major Product Offerings
7.9.4 ChemPartner Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.9.5 ChemPartner Key News
7.10 JOINN Lab
7.10.1 JOINN Lab Corporate Summary
7.10.2 JOINN Lab Business Overview
7.10.3 JOINN Lab Preclinical Drug Development Services Major Product Offerings
7.10.4 JOINN Lab Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.10.5 JOINN Lab Key News
7.11 EVOTEC
7.11.1 EVOTEC Corporate Summary
7.11.2 EVOTEC Business Overview
7.11.3 EVOTEC Preclinical Drug Development Services Major Product Offerings
7.11.4 EVOTEC Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.11.5 EVOTEC Key News
7.12 Medicilon
7.12.1 Medicilon Corporate Summary
7.12.2 Medicilon Business Overview
7.12.3 Medicilon Preclinical Drug Development Services Major Product Offerings
7.12.4 Medicilon Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.12.5 Medicilon Key News
7.13 Noble Life Sciences
7.13.1 Noble Life Sciences Corporate Summary
7.13.2 Noble Life Sciences Business Overview
7.13.3 Noble Life Sciences Preclinical Drug Development Services Major Product Offerings
7.13.4 Noble Life Sciences Preclinical Drug Development Services Revenue in Global Market (2017-2022)
7.13.5 Noble Life Sciences Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Preclinical Drug Development Services Market Opportunities & Trends in Global Market
Table 2. Preclinical Drug Development Services Market Drivers in Global Market
Table 3. Preclinical Drug Development Services Market Restraints in Global Market
Table 4. Key Players of Preclinical Drug Development Services in Global Market
Table 5. Top Preclinical Drug Development Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Preclinical Drug Development Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Preclinical Drug Development Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Preclinical Drug Development Services Product Type
Table 9. List of Global Tier 1 Preclinical Drug Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Preclinical Drug Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Preclinical Drug Development Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Preclinical Drug Development Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Preclinical Drug Development Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Preclinical Drug Development Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Preclinical Drug Development Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Preclinical Drug Development Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Preclinical Drug Development Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Preclinical Drug Development Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Preclinical Drug Development Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Preclinical Drug Development Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Preclinical Drug Development Services Revenue, (US$, Mn), 2023-2028
Table 30. Wuxi AppTec Corporate Summary
Table 31. Wuxi AppTec Preclinical Drug Development Services Product Offerings
Table 32. Wuxi AppTec Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 33. Labcorp Corporate Summary
Table 34. Labcorp Preclinical Drug Development Services Product Offerings
Table 35. Labcorp Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 36. Charles River Corporate Summary
Table 37. Charles River Preclinical Drug Development Services Product Offerings
Table 38. Charles River Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 39. Eurofins Scientific Corporate Summary
Table 40. Eurofins Scientific Preclinical Drug Development Services Product Offerings
Table 41. Eurofins Scientific Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 42. PPD, Inc. Corporate Summary
Table 43. PPD, Inc. Preclinical Drug Development Services Product Offerings
Table 44. PPD, Inc. Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 45. ICON Plc. Corporate Summary
Table 46. ICON Plc. Preclinical Drug Development Services Product Offerings
Table 47. ICON Plc. Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 48. Pharmaron Corporate Summary
Table 49. Pharmaron Preclinical Drug Development Services Product Offerings
Table 50. Pharmaron Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 51. Inotiv Corporate Summary
Table 52. Inotiv Preclinical Drug Development Services Product Offerings
Table 53. Inotiv Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 54. ChemPartner Corporate Summary
Table 55. ChemPartner Preclinical Drug Development Services Product Offerings
Table 56. ChemPartner Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 57. JOINN Lab Corporate Summary
Table 58. JOINN Lab Preclinical Drug Development Services Product Offerings
Table 59. JOINN Lab Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 60. EVOTEC Corporate Summary
Table 61. EVOTEC Preclinical Drug Development Services Product Offerings
Table 62. EVOTEC Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 63. Medicilon Corporate Summary
Table 64. Medicilon Preclinical Drug Development Services Product Offerings
Table 65. Medicilon Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
Table 66. Noble Life Sciences Corporate Summary
Table 67. Noble Life Sciences Preclinical Drug Development Services Product Offerings
Table 68. Noble Life Sciences Preclinical Drug Development Services Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Preclinical Drug Development Services Segment by Type in 2021
Figure 2. Preclinical Drug Development Services Segment by Application in 2021
Figure 3. Global Preclinical Drug Development Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Preclinical Drug Development Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Preclinical Drug Development Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Preclinical Drug Development Services Revenue in 2021
Figure 8. By Type - Global Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 12. US Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 16. Germany Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 24. China Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 30. Brazil Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Preclinical Drug Development Services Revenue Market Share, 2017-2028
Figure 33. Turkey Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Preclinical Drug Development Services Revenue, (US$, Mn), 2017-2028
Figure 37. Wuxi AppTec Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Labcorp Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Charles River Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Eurofins Scientific Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. PPD, Inc. Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ICON Plc. Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Pharmaron Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Inotiv Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. ChemPartner Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. JOINN Lab Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. EVOTEC Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Medicilon Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Noble Life Sciences Preclinical Drug Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
